Legal & General Group’s 10x Genomics TXG Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.28M | Buy |
110,864
+5,985
| +6% | +$69.3K | ﹤0.01% | 2160 |
|
2025
Q1 | $916K | Buy |
104,879
+3,034
| +3% | +$26.5K | ﹤0.01% | 2216 |
|
2024
Q4 | $1.46M | Sell |
101,845
-113
| -0.1% | -$1.62K | ﹤0.01% | 2111 |
|
2024
Q3 | $2.3M | Buy |
101,958
+12,642
| +14% | +$285K | ﹤0.01% | 1908 |
|
2024
Q2 | $1.74M | Buy |
89,316
+4,359
| +5% | +$84.8K | ﹤0.01% | 1999 |
|
2024
Q1 | $3.19M | Buy |
84,957
+602
| +0.7% | +$22.6K | ﹤0.01% | 1728 |
|
2023
Q4 | $4.72M | Buy |
84,355
+501
| +0.6% | +$28K | ﹤0.01% | 1530 |
|
2023
Q3 | $3.46M | Sell |
83,854
-1,884
| -2% | -$77.7K | ﹤0.01% | 1638 |
|
2023
Q2 | $4.79M | Buy |
85,738
+660
| +0.8% | +$36.9K | ﹤0.01% | 1485 |
|
2023
Q1 | $4.75M | Buy |
85,078
+6,680
| +9% | +$373K | ﹤0.01% | 1441 |
|
2022
Q4 | $2.86M | Sell |
78,398
-7,331
| -9% | -$267K | ﹤0.01% | 1704 |
|
2022
Q3 | $2.44M | Sell |
85,729
-23,524
| -22% | -$670K | ﹤0.01% | 1761 |
|
2022
Q2 | $4.94M | Sell |
109,253
-210,088
| -66% | -$9.51M | ﹤0.01% | 1416 |
|
2022
Q1 | $24.3M | Buy |
319,341
+66,228
| +26% | +$5.04M | 0.01% | 831 |
|
2021
Q4 | $37.7M | Sell |
253,113
-19,761
| -7% | -$2.94M | 0.01% | 741 |
|
2021
Q3 | $39.7M | Buy |
272,874
+10,384
| +4% | +$1.51M | 0.01% | 720 |
|
2021
Q2 | $51.4M | Buy |
262,490
+78,846
| +43% | +$15.4M | 0.02% | 683 |
|
2021
Q1 | $33.2M | Buy |
183,644
+11,636
| +7% | +$2.11M | 0.01% | 749 |
|
2020
Q4 | $24.4M | Buy |
172,008
+140,135
| +440% | +$19.8M | 0.01% | 789 |
|
2020
Q3 | $3.97M | Buy |
31,873
+10,107
| +46% | +$1.26M | ﹤0.01% | 1455 |
|
2020
Q2 | $1.94M | Buy |
+21,766
| New | +$1.94M | ﹤0.01% | 1744 |
|
2020
Q1 | – | Sell |
-7,000
| Closed | -$532K | – | 3358 |
|
2019
Q4 | $532K | Buy |
7,000
+1,500
| +27% | +$114K | ﹤0.01% | 2208 |
|
2019
Q3 | $278K | Buy |
+5,500
| New | +$278K | ﹤0.01% | 2285 |
|